TY - JOUR
AB - DOI:10.1002/cind.7910_11.x Download the C&I app from iTunes and Google Play Global perspective Drug manufacturers in India are being given new government guidelines in a bid to improve quality control he Indian government seven warning letters to Indian ‘From October 2015, all Indian drug is preparing a new set of pharma companies. This number companies will have to adhere to the guidelines to regulate drug reduced to six in 2014. Only two Tquality in India. The move letters have been received so far in prescribed manufacturing data with has been prompted by the recent 2015. regards to dier ff ent levels of packaging. actions by the US Food and Drugs Despite the difficulties, India’s Administration (FDA), which has pharma exports also soared to All consignments of drugs will henceforth come across so many instances of $15.3bn in 2014-15. However, an poor quality control that is has been EU ban that came into effect on 21 be “tracked and traced” right from the compelled to issue either warning August 2015 on the sale of around manufacturing unit in India until they letters or import alerts against a 700 generic drugs clinically tested by number of Indian pharmaceutical Hyderabad-based GVK Biosciences arrive 
TI - Quality counts
JF - Chemistry & Industry
DO - 10.1002/cind.7910_11.x
DA - 2015-10-01
UR - https://www.deepdyve.com/lp/wiley/quality-counts-ikjus9j57g
SP - 31
EP - 31
VL - 79
IS - 10
DP - DeepDyve
ER -